• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在重症肌无力康复和管理中的应用前景。

Application Prospect of Artificial Intelligence in Rehabilitation and Management of Myasthenia Gravis.

机构信息

Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

出版信息

Biomed Res Int. 2021 Mar 4;2021:5592472. doi: 10.1155/2021/5592472. eCollection 2021.

DOI:10.1155/2021/5592472
PMID:33763475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7952150/
Abstract

Myasthenia gravis (MG) is a chronic autoimmune disease of the nervous system, which is still incurable. In recent years, with the progress of immunosuppressive and supportive treatment, the therapeutic effect of MG in the acute stage is satisfactory, and the mortality rate has been greatly reduced. However, there is still no consensus on how to conduct long-term management of stable MG, such as guiding patients to identify relapses, practice exercise, return to work and school, etc. In the international consensus guidance for management of myasthenia gravis published by the Myasthenia Gravis Foundation of America (MGFA) in 2020, for the first time, "the role of physical training/exercise in MG" was identified as the topic of discussion. Finally, due to a lack of high-quality evidence on physical training/exercise in patients with MG, the topic was excluded after the literature review. Therefore, this paper reviewed the current status of MG rehabilitation research and the difficulties faced by stable MG patients in self-management. It is suggested that we should take advantage of artificial intelligence (AI) and leverage it to develop the data-driven decision support platforms for MG management which can be used for adverse event monitoring, disease education, chronic management, and a wide variety of data collection and analysis.

摘要

重症肌无力(MG)是一种慢性自身免疫性神经系统疾病,目前仍然无法治愈。近年来,随着免疫抑制和支持治疗的进展,MG 急性期的治疗效果令人满意,死亡率大大降低。然而,对于稳定期 MG 的长期管理,如指导患者识别复发、进行锻炼、重返工作和学校等,仍没有共识。2020 年,美国重症肌无力基金会(MGFA)在发布的重症肌无力管理国际共识指南中,首次将“体力训练/锻炼在 MG 中的作用”确定为讨论主题。最后,由于缺乏重症肌无力患者体力训练/锻炼的高质量证据,在文献回顾后,该主题被排除。因此,本文综述了 MG 康复研究的现状以及稳定期 MG 患者在自我管理中面临的困难。建议利用人工智能(AI)并借助其开发用于 MG 管理的数据驱动决策支持平台,可用于不良事件监测、疾病教育、慢性管理以及各种数据收集和分析。

相似文献

1
Application Prospect of Artificial Intelligence in Rehabilitation and Management of Myasthenia Gravis.人工智能在重症肌无力康复和管理中的应用前景。
Biomed Res Int. 2021 Mar 4;2021:5592472. doi: 10.1155/2021/5592472. eCollection 2021.
2
Physical training and exercise in myasthenia gravis.重症肌无力的体能训练与运动。
Neuromuscul Disord. 2021 Mar;31(3):169-173. doi: 10.1016/j.nmd.2020.12.004. Epub 2020 Dec 24.
3
Thymectomy in severe (Myasthenia Gravis Foundation of America classes IV-V) generalized myasthenia gravis: is the game really worth the candle?重症肌无力(美国重症肌无力基金会 IV-V 级)胸腺切除术:这场游戏真的值得吗?
Eur J Cardiothorac Surg. 2023 May 2;63(5). doi: 10.1093/ejcts/ezad179.
4
Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis.重症肌无力的低剂量药物治疗与长期预后
J Clin Neuromuscul Dis. 2016 Dec;18(2):61-66. doi: 10.1097/CND.0000000000000122.
5
Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis.他克莫司治疗重症肌无力的长期安全性和有效性。
Yonsei Med J. 2019 Jul;60(7):633-639. doi: 10.3349/ymj.2019.60.7.633.
6
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.在重症肌无力(PROMISE-MG)中,硫唑嘌呤和霉酚酸酯的疗效比较:一项前瞻性队列研究。
Lancet Neurol. 2024 Mar;23(3):267-276. doi: 10.1016/S1474-4422(24)00028-0.
7
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.国际重症肌无力管理共识指南:2020 年更新版。
Neurology. 2021 Jan 19;96(3):114-122. doi: 10.1212/WNL.0000000000011124. Epub 2020 Nov 3.
8
Ocular myasthenia gravis: response to long-term immunosuppressive treatment.眼肌型重症肌无力:长期免疫抑制治疗的反应
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):156-62. doi: 10.1136/jnnp.62.2.156.
9
International consensus guidance for management of myasthenia gravis: Executive summary.重症肌无力管理的国际共识指南:执行摘要。
Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29.
10
Benefits of Comprehensive Rehabilitation Therapy in Thymectomy for Myasthenia Gravis: A Propensity Score Matching Analysis.综合康复治疗在重症肌无力胸腺切除术中的益处:倾向评分匹配分析
Am J Phys Med Rehabil. 2017 Feb;96(2):77-83. doi: 10.1097/PHM.0000000000000538.

引用本文的文献

1
Applications of Machine Learning (ML) and Mathematical Modeling (MM) in Healthcare with Special Focus on Cancer Prognosis and Anticancer Therapy: Current Status and Challenges.机器学习(ML)和数学建模(MM)在医疗保健中的应用,特别关注癌症预后和抗癌治疗:现状与挑战
Pharmaceutics. 2024 Feb 9;16(2):260. doi: 10.3390/pharmaceutics16020260.
2
Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system.系统生物学和人工智能分析突出了静脉注射免疫球蛋白治疗在以 B 细胞和补体系统为主导的自身免疫性疾病中的多效性作用。
Front Immunol. 2022 Sep 30;13:901872. doi: 10.3389/fimmu.2022.901872. eCollection 2022.
3
Integration of Artificial Intelligence, Blockchain, and Wearable Technology for Chronic Disease Management: A New Paradigm in Smart Healthcare.人工智能、区块链和可穿戴技术在慢性病管理中的整合:智能医疗保健的新模式。
Curr Med Sci. 2021 Dec;41(6):1123-1133. doi: 10.1007/s11596-021-2485-0. Epub 2021 Dec 24.

本文引用的文献

1
Precision medicine in the era of artificial intelligence: implications in chronic disease management.人工智能时代的精准医学:在慢性病管理中的应用。
J Transl Med. 2020 Dec 9;18(1):472. doi: 10.1186/s12967-020-02658-5.
2
An artificial intelligence decision support system for the management of type 1 diabetes.用于 1 型糖尿病管理的人工智能决策支持系统。
Nat Metab. 2020 Jul;2(7):612-619. doi: 10.1038/s42255-020-0212-y. Epub 2020 Jun 1.
3
Application of Artificial Intelligence in Diabetes Education and Management: Present Status and Promising Prospect.人工智能在糖尿病教育和管理中的应用:现状与前景展望。
Front Public Health. 2020 May 29;8:173. doi: 10.3389/fpubh.2020.00173. eCollection 2020.
4
Predicting conversion to wet age-related macular degeneration using deep learning.使用深度学习预测湿性年龄相关性黄斑变性的转化。
Nat Med. 2020 Jun;26(6):892-899. doi: 10.1038/s41591-020-0867-7. Epub 2020 May 18.
5
Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas.基于术前 CT 的深度学习模型预测肺腺癌患者无病生存。
Radiology. 2020 Jul;296(1):216-224. doi: 10.1148/radiol.2020192764. Epub 2020 May 12.
6
The need for a system view to regulate artificial intelligence/machine learning-based software as medical device.需要一种系统观点来将基于人工智能/机器学习的软件作为医疗设备进行监管。
NPJ Digit Med. 2020 Apr 7;3:53. doi: 10.1038/s41746-020-0262-2. eCollection 2020.
7
Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy.机器学习在脓毒症预测中的应用:诊断试验准确性的系统评价和荟萃分析。
Intensive Care Med. 2020 Mar;46(3):383-400. doi: 10.1007/s00134-019-05872-y. Epub 2020 Jan 21.
8
International evaluation of an AI system for breast cancer screening.国际乳腺癌筛查人工智能系统评估。
Nature. 2020 Jan;577(7788):89-94. doi: 10.1038/s41586-019-1799-6. Epub 2020 Jan 1.
9
A prospective multicentre study testing the diagnostic accuracy of an automated cough sound centred analytic system for the identification of common respiratory disorders in children.一项前瞻性多中心研究,旨在测试一种以咳嗽声为中心的自动分析系统在识别儿童常见呼吸道疾病方面的诊断准确性。
Respir Res. 2019 Jun 6;20(1):81. doi: 10.1186/s12931-019-1046-6.
10
A longitudinal big data approach for precision health.纵向大数据方法用于精准健康。
Nat Med. 2019 May;25(5):792-804. doi: 10.1038/s41591-019-0414-6. Epub 2019 May 8.